Select Page


Below is a sample of existing clinical evidence:

“The administration of a single dose of bone marrow- or adipose tissue-derived MSCs reduced continuous chronic alcohol intake by 50% during 10 days… Animals treated with MSCs significantly reduced up to 80–85% their relapse-like alcohol intake compared to control rats… significantly inhibited relapse-like drinking for the 40 days investigated, suggesting a protracted remodeling.”

– “Intracerebral Stem Cell Administration Inhibits Relapse-like Alcohol Drinking in Rats,” Israel et al, Alcohol and Alcoholism, 2017

Pin It on Pinterest

Share This